NASDAQ
PRVA
Last Price
US $26.88
KEY FIGURES
MKT CAP
$3.2B
EPS
TTM
$0.18
PEG
TTM
3.76x
P/E
TTM
144.54x
P/S
TTM
1.52x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Privia Health Group, Inc. cash flow to debt ratio of 1.71K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial stability - Healthy cash flow growth.
Privia Health Group, Inc.'s free cash flow has increased 55.57% from $104.26M last year to $162.20M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Privia Health Group, Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Privia Health Group, Inc.'s debt has increased relative to shareholder equity from 0.01 last year to 0.01 today, signaling weakened financials
Financial stability - Net debt/EBITDA.
Privia Health Group, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Privia Health Group, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Privia Health Group, Inc.'s profit margin has increased (16.93%) in the last year from 0.83% to 0.97%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Privia Health Group, Inc.'s short-term assets of $911.00M exceed its short-term liabilities of $568.52M
Decreasing performance - ROA.
Privia Health Group, Inc.'s return on assets of 1.53% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Privia Health Group, Inc.'s return on equity of 3.02%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Privia Health Group, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Privia Health Group, Inc. had positive net income in 3.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Privia Health Group, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Privia Health Group, Inc. has a free cash flow yield of 5.03%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Privia Health Group, Inc.'s yearly earnings has increased 59.33% since last year from $14.38M to $22.92M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Privia Health Group, Inc.'s yearly revenue has increased 22.26% since last year from $1.74G to $2.12G, signaling increasing performance
Decreasing performance - ROIC.
ROIC 2.70% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Privia Health Group, Inc.'s 3-year revenue CAGR of 16.10% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Privia Health Group, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Privia Health Group, Inc. had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity
Undervalued - DCF valuation.
Privia Health Group, Inc. is undervalued relative to its fair value price of 27.08 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Privia Health Group, Inc. has an earnings yield of 0.69%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Privia Health Group, Inc. is overvalued relative to its fair value price of 6.30 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Privia Health Group, Inc. has an EV/EBITDA ratio of 49.86x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Overvalued - PEG ratio value.
Privia Health Group, Inc. has a PEG-ratio over 1 which is considered overvalued
Undervalued - P/B ratio.
Privia Health Group, Inc. has a price-to-book ratio of 4.22x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Privia Health Group, Inc. has a price-to-sales ratio of 1.43x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
3.02%
Return on equity
ROIC: 2.70%
Valuation History
144.5X
Price to Earnings
EV/EBITDA: 49.9X
Cash flow
Profit margin
21.04%
(FY vs FY)
EBITDA Y/Y
14.62%
(FY vs FY)
Cash flow Y/Y
33.32%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $26.88
0.74%
Default assumptions
EBITDA Multiple
Fair Value
Market $26.88
-76.56%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.